RESEARCH PAPER
A cross-sectional study on tobacco use and dependence among women: Does menthol matter?
Judith Rosenbloom 1, 2
,  
Kathleen Reid 1, 4
,  
Jeannie Wong 1, 5
,  
 
 
More details
Hide details
1
Tobacco Dependence Treatment & Research, Department of Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Harvard Medical School, Boston, USA
2
Total Health Care, Baltimore, USA
3
Center for Global Tobacco Control, Department of Society, Human Development and Health, Harvard School of Public Health, Boston, USA
4
Department of Psychiatry, Boston Medical Center, Boston, USA
5
Oliver Wyman, Health & Life Sciences, New York, USA
CORRESPONDING AUTHOR
Taru Kinnunen   

Tobacco Dependence Treatment & Research, Department of Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Harvard Medical School, 188 Longwood Avenue, Boston, MA 02115, USA
Publish date: 2012-11-27
 
Tobacco Induced Diseases 2012;10(November):19
KEYWORDS
ABSTRACT
Background:
The question of whether mentholation of cigarettes enhances tobacco dependence has generated conflicting findings. Potential mediating factors in a putative relationship between menthol use and tobacco dependence may include race and gender. While an association between menthol use and dependence is mixed, research on the role of race solely among women smokers is scarce. This study examined whether women menthol smokers have higher tobacco use and dependence than non-menthol smokers. Further, the study investigated differences between White and African American smokers.

Methods:
A cross-sectional study was conducted among 928 women seeking tobacco dependence treatment in Boston, Massachusetts. Measures obtained included preferred brand and menthol content, dependence markers (cigarettes per day (CPD); time to first cigarette in the morning; number of and longest previous quit attempts) and smoking history (age of initiation; years smoking; menthol or non-menthol cigarette preference). Analysis of variance (ANOVA) was used to detect interactions between menthol preference by race for continuous variables, and Pearson’s chi-squared test was used for analyses with dichotomous variables.

Results:
A greater proportion of menthol smokers smoked their first cigarette within five minutes of waking (p < 0.01) and were less likely to have a previous quit attempt longer than 90 days (p < 0.01). ANOVAs revealed no main effects for menthol preferences. However, African American smokers smoked fewer CPD (p<.001), started smoking later in life (p= .04), and had been smoking the same brand for longer (p= .04).

Conclusions:
Women menthol smokers showed signs of greater tobacco dependence than non-menthol smokers. African Americans smoked fewer CPD but nevertheless had evidence of greater dependence.

 
REFERENCES (40)
1.
Gardiner PS: The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res. 2004, 6 (Suppl 1): S55-S65.
 
2.
Giovino GA, Sidney S, Gfroerer JC, O’Malley PM, Allen JA, Richter PA, Cummings KM: Epidemiology of menthol cigarette use. Nicotine Tob Res. 2004, 6 (Suppl 1): S67-S81.
 
3.
Caraballo RS, Asman K: Epidemiology of menthol cigarette use in the United States. Tob Induc Dis. 2011, 9 (Suppl 1): S1-10.1186/1617-9625-9-S1-S1.
 
4.
Hoffman AC: The health effects of menthol cigarettes as compared to non-menthol cigarettes. Tob Induc Dis. 2011, 9 (Suppl 1): S7-10.1186/1617-9625-9-S1-S7.
 
5.
Lee PN: Systematic review of the epidemiological evidence comparing lung cancer risk in smokers of mentholated and unmentholated cigarettes. BMC Pulm Med. 2011, 11: 18-10.1186/1471-2466-11-18.
 
6.
Public Law 111-31, H.R. 1256: http://www.gpo.gov/fdsys/pkg/P... (accessed 25 Sept 2012).
 
7.
Hoffman AC, Miceli D: Menthol cigarettes and smoking cessation behavior. Tob Induc Dis. 2011, 9 (Suppl 1): S6-10.1186/1617-9625-9-S1-S6.
 
8.
Hoffman AC, Simmons D: Menthol cigarette smoking and nicotine dependence. Tob Induc Dis. 2011, 9 (Suppl 1): S5-10.1186/1617-9625-9-S1-S5.
 
9.
Rising J, Wasson-Blader K: Menthol and initiation of cigarette smoking. Tob Induc Dis. 2011, 9 (Suppl 1): S4-10.1186/1617-9625-9-S1-S4.
 
10.
Rising J, Alexander L: Marketing of menthol cigarettes and consumer perceptions. Tob Induc Dis. 2011, 9 (Suppl 1): S2-10.1186/1617-9625-9-S1-S2.
 
11.
Lawrence D, Cadman B, Hoffman AC: Sensory properties of menthol and smoking topography. Tob Induc Dis. 2011, 9 (Suppl 1): S3.
 
12.
Royce JM, Hymowitz N, Corbett K, Hartwell TD, Orlandi MA: Smoking cessation factors among African Americans and Whites. Am J Public Health. 1993, 83: 220-226. 10.2105/AJPH.83.2.220.
 
13.
Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, Jacobs DR: Racial differences in serum cotinine levels among smokers in Coronary Artery Risk Development in (Young) Adults study. Am J Public Health. 1990, 80: 1053-1056. 10.2105/AJPH.80.9.1053.
 
14.
Garten S, Falkner RV: Role of mentholated cigarettes in increased nicotine dependence and greater risk of tobacco-attributable disease. Prev Med. 2004, 38: 793-798. 10.1016/j.ypmed.2004.01.019.
 
15.
Hyland A, Garten S, Giovino GA, Cummings KM: Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation. Tob Control. 2002, 11: 135-139. 10.1136/tc.11.2.135.
 
16.
Novotny TE, Warner KE, Kendrick JS, Remington PL: Smoking by Blacks and Whites: socioeconomic and demographic differences. Am J Public Health. 1988, 78: 1187-1189. 10.2105/AJPH.78.9.1187.
 
17.
Perez-Stable EJ, Herrera B, Jacob P, Benowitz NL: Nicotine metabolism and intake in black and white smokers. JAMA. 1998, 280: 152-156. 10.1001/jama.280.2.152.
 
18.
Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, Sharp DJ, Eriksen MP, Pirkle JL, Maurer KR: Racial and ethnic differences in serum cotinine levels of cigarette smokers. JAMA. 1998, 280: 135-139. 10.1001/jama.280.2.135.
 
19.
Clark PI, Gautam S, Gerson LW: Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest. 1996, 110: 1194-1198. 10.1378/chest.110.5.1194.
 
20.
Mustonen TK, Spencer SM, Hoskinson RA, Sachs DPL, Garvey AJ: The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res. 2005, 7: 581-590. 10.1080/14622200500185199.
 
21.
Allen B, Unger JB: Sociocultural correlates of menthol cigarette smoking among adult Africa Americans in Los Angeles. Nicotine Tob Res. 2007, 9: 447-451.
 
22.
Centers for Disease Control and Prevention (CDC): Cigarette smoking-attributable morbidity – United States, 2000. MMWR Morb Mortal Wkly Rep. 2003, 52: 842-844.
 
23.
World Health Organization: WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package. 2008, Geneva: World Health Organization.
 
24.
Henningfield JE, Benowitz NL, Ahijevych K, Garrett BE, Connolly GN, Wayne GF: Does menthol enhance the addictiveness of cigarettes? An agenda for research. Nicotine Tob Res. 2003, 5: 9-11. 10.1080/1462220031000070543.
 
25.
Muscat JE, Richie JP, Stellman SD: Mentholated cigarettes and smoking habits in whites and blacks. Tob Control. 2002, 11: 368-371. 10.1136/tc.11.4.368.
 
26.
Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S: Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med. 2006, 166: 1915-1922. 10.1001/archinte.166.17.1915.
 
27.
Centers for Disease Control and Prevention (CDC): Tobacco use among U.S. racial/ethnic groups – African Americans, American India and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics. A Report of the Surgeon General. Executive summary. MMWR Recomm Rep. 1998, 47: 1-16.
 
28.
Richardson TL: African-American smokers and cancers of the lung and of the upper respiratory and digestive tracts: Is menthol part of the puzzle?. Wes J Med. 1997, 166: 189-194.
 
29.
Benowitz NL, Herrera B, Jacob P: Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther. 2004, 310: 1208-1215. 10.1124/jpet.104.066902.
 
30.
Schmeltz I, Schlotzhauer WS: Benzo[a]pyrene, phenols, and other products of pyrolysis of the cigarette additive, (d, l)-Menthol. Nature. 1968, 219: 370-371.
 
31.
Brooks DR, Palmer JR, Strom BL, Rosenberg L: Menthol cigarettes and risk of lung cancer. Am J Epidemiol. 2003, 158: 609-616. 10.1093/aje/kwg182.
 
32.
Werley MS, Coggins CR, Lee PN: Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions. Regul Toxicol Pharmacol. 2007, 47: 189-203. 10.1016/j.yrtph.2006.09.004.
 
33.
Korhonen T, Goodwin A, Miesmaa P, Dupuis EA, Kinnunen T: Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. J Women’s Health (Larchmt). 2011, 20: 1051-1064. 10.1089/jwh.2010.2075.
 
34.
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoke per day. Br J Addict. 1989, 84: 791-799. 10.1111/j.1360-0443.1989.tb03059.x.
 
35.
Baker TB, Piper ME, McCarthy DE, Bold DM, Smith SS, Kim SY, Colby S, Conti D, Giovino GA, Hatsukami D, Hyland A, Krishnana-Sarin S, Niaura R, Perkins KA, Toll BA, Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence: Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res. 2007, 9 (4): S555-S570.
 
36.
Okuyemi KS, Ebersole-Robinson M, Nazir N, Ahluwalia JS: African-American menthol and nonmenthol smokers: differences in smoking and cessation experiences. J Natl Med Assoc. 2004, 96: 1208-1211.
 
37.
Ahijevych K, Parsley LA: Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav. 1999, 24: 115-120. 10.1016/S0306-4603(98)00031-8.
 
38.
Azzi C, Zhang J, Purdon CH, Chapman JM, Nitcheva D, Hebert JR, Smith EW: Permeation and reservoir formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P) across porcine esophageal tissue in the presence of ethanol and menthol. Carcinogenesis. 2006, 27: 137-145.
 
39.
Garten S, Falkner RV: Continual smoking of mentholated cigarettes may mask the early warning symptoms of respiratory disease. Prev Med. 2003, 37: 291-296. 10.1016/S0091-7435(03)00116-6.
 
40.
Jarvis MJ, Wardle J, Waller J, Owen J: Prevalence of hardcore smoking in England, and associated attitudes and beliefs: cross-sectional study. BMJ. 2003, 326: 1061-10.1136/bmj.326.7398.1061.
 
 
CITATIONS (11):
1.
Menthol Cigarettes, Time to First Cigarette, and Smoking Cessation
Edward Sanders, Rolf Weitkunat, Ruth Dempsey
Beiträge zur Tabakforschung International/Contributions to Tobacco Research
 
2.
Menthol enhances nicotine-induced locomotor sensitization and in vivo functional connectivity in adolescence
Matthew F Thompson, Guillaume L Poirier, Martha I Dávila-García, Wei Huang, Kelly Tam, Maxwell Robidoux, Michelle L Dubuke, Scott A Shaffer, Luis Colon-Perez, Marcelo Febo, Joseph R DiFranza, Jean A King
Journal of Psychopharmacology
 
3.
Menthol cigarettes and the public health standard: a systematic review
Andrea C. Villanti, Lauren K. Collins, Raymond S. Niaura, Stacey Y. Gagosian, David B. Abrams
BMC Public Health
 
4.
Menthol Attenuates Respiratory Irritation and Elevates Blood Cotinine in Cigarette Smoke Exposed Mice
Michael A. Ha, Gregory J. Smith, Joseph A. Cichocki, Lu Fan, Yi-Shiuan Liu, Ana I. Caceres, Sven Eric Jordt, John B. Morris, David D McKemy
PLOS ONE
 
5.
The lingering question of menthol in cigarettes
Ahmad Besaratinia, Stella Tommasi
Cancer Causes & Control
 
6.
Determining non-cigarette tobacco, alcohol, and substance use typologies across menthol and non-menthol smokers using latent class analysis
Amy Cohn, Amanda Johnson, Jennifer Pearson, Shyanika Rose, Sarah Ehlke, Ollie Ganz, Raymond Niaura
Tobacco Induced Diseases
 
7.
Use of flavoured cigarettes in Poland: data from the global adult tobacco survey (2009–2010)
Dorota Kaleta, Bukola Usidame, Anna Szosland-Fałtyn, Teresa Makowiec-Dąbrowska
BMC Public Health
 
8.
Menthol cigarette smoking in the COPDGene cohort: Relationship with COPD, comorbidities and CT metrics
Seoung Ju Park, Marilyn G. Foreman, Dawn L. Demeo, Surya P. Bhatt, Nadia N. Hansel, Robert A. Wise, Xavier Soler, Russell P. Bowler
Respirology
 
9.
Menthol disrupts nicotine’s psychostimulant properties in an age and sex-dependent manner in C57BL/6J mice
Benjamin W. Fait, David C. Thompson, Tenna N. Mose, Peter Jatlow, Sven E. Jordt, Marina R Picciotto, Yann S. Mineur
Behavioural Brain Research
 
10.
Predictors, Indicators, and Validated Measures of Dependence in Menthol Smokers
Kimberly Frost-Pineda, Raheema Muhammad-Kah, Lonnie Rimmer, Qiwei Liang
Journal of Addictive Diseases
 
11.
Effects of Menthol Flavor Cigarettes or Total Urinary Menthol on Biomarkers of Nicotine and Carcinogenic Exposure and Behavioral Measures
Karen Ahijevych, Laura A Szalacha, Alai Tan
Nicotine & Tobacco Research
 
eISSN:1617-9625